{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:52:24Z","timestamp":1787593944311,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500534, 31372562, 81470935, 81402105, 81670645, 81602236"],"award-info":[{"award-number":["81500534, 31372562, 81470935, 81402105, 81670645, 81602236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0980-8","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T12:19:00Z","timestamp":1530879540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of Hydroxy-L-proline (HYP) analogs in the treatment of primary hyperoxaluria in Drosophila Melanogaster"],"prefix":"10.1186","volume":"19","author":[{"given":"Huan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Male","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangqun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"2","key":"980_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MOU.0b013e328323a81d","volume":"19","author":"CR Tracy","year":"2009","unstructured":"Tracy CR, Pearle MS. Update on the medical management of stone disease. Curr Opin Urol. 2009;19(2):200\u20134.","journal-title":"Curr Opin Urol"},{"issue":"5","key":"980_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00240-005-0493-3","volume":"33","author":"JI Scheinman","year":"2005","unstructured":"Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Urol Res. 2005;33(5):368\u201371.","journal-title":"Urol Res"},{"issue":"4","key":"980_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ki.2011.80","volume":"80","author":"YH Chen","year":"2011","unstructured":"Chen YH, Liu HP, Chen HY, Tsai FJ, Chang CH, Lee YJ, Lin WY, Chen WC. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis\/urolithiasis. Kidney Int. 2011;80(4):369\u201377.","journal-title":"Kidney Int"},{"issue":"11","key":"980_CR4","doi-asserted-by":"publisher","first-page":"F1555","DOI":"10.1152\/ajprenal.00074.2012","volume":"303","author":"T Hirata","year":"2012","unstructured":"Hirata T, Cabrero P, Berkholz DS, Bondeson DP, Ritman EL, Thompson JR, Dow JA, Romero MF. In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis. Am J Physiol Renal Physiol. 2012;303(11):F1555\u201362.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"980_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00240-016-0860-2","volume":"44","author":"O Clifford-Mobley","year":"2016","unstructured":"Clifford-Mobley O, Sj\u00f6gren A, Lindner E, Rumsby G. Urine oxalate biological variation in patients with primary hyperoxaluria. Urolithiasis. 2016;44(4):333\u20137.","journal-title":"Urolithiasis"},{"issue":"4","key":"980_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cqn.2013.11.009","volume":"2","author":"SB Raju","year":"2013","unstructured":"Raju SB. Primary hyperoxaluria. Clin Queries Nephrol. 2013;2(4):179\u201383.","journal-title":"Clin Queries Nephrol"},{"key":"980_CR7","doi-asserted-by":"publisher","first-page":"864580","DOI":"10.4061\/2011\/864580","volume":"2011","author":"J Harambat","year":"2011","unstructured":"Harambat J, Fargue S, Bacchetta J, Acquaviva C, Cochat P. Primary hyperoxaluria. Int J Nephrol. 2011;2011:864580.","journal-title":"Int J Nephrol"},{"issue":"2","key":"980_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5527\/wjn.v4.i2.235","volume":"4","author":"B Bhasin","year":"2015","unstructured":"Bhasin B, Urekli HM, Atta MG. Primary and secondary hyperoxaluria: understanding the enigma. World J Nephrol. 2015;4(2):235\u201344.","journal-title":"World J Nephrol"},{"issue":"9","key":"980_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.bbadis.2012.03.004","volume":"1822","author":"E Salido","year":"2012","unstructured":"Salido E, Pey AL, Rodriguez R, Lorenzo V. Primary hyperoxalurias: disorders of glyoxylate detoxification. Biochim Biophys Acta. 2012;1822(9):1453\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"980_CR10","first-page":"398","volume":"34","author":"V Lorenzo","year":"2014","unstructured":"Lorenzo V, Torres A, Salido E. Primary hyperoxaluria. Nefrologia. 2014;34(3):398\u2013412.","journal-title":"Nefrologia"},{"issue":"12","key":"980_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/hepr.12494","volume":"45","author":"T Kogiso","year":"2015","unstructured":"Kogiso T, Tokushige K, Hashimoto E, Miyakata C, Taniai M, Torii N, Omori A, Kotera Y, Egawa H, Yamamoto M. Primary hyperoxaluria complicated with liver cirrhosis: a case report. Hepatol Res. 2015;45(12):1251\u20135.","journal-title":"Hepatol Res"},{"issue":"4","key":"980_CR12","doi-asserted-by":"publisher","first-page":"e94338","DOI":"10.1371\/journal.pone.0094338","volume":"9","author":"MD Lage","year":"2014","unstructured":"Lage MD, Pittman AM, Roncador A, Cellini B, Tucker CL. Allele-specific characterization of alanine: glyoxylate aminotransferase variants associated with primary hyperoxaluria. PLoS One. 2014;9(4):e94338.","journal-title":"PLoS One"},{"issue":"2","key":"980_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/BJ20141159","volume":"466","author":"CB Summitt","year":"2015","unstructured":"Summitt CB, Johnson LC, Jonsson TJ, Parsonage D, Holmes RP, Lowther WT. Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria. Biochem J. 2015;466(2):273\u201381.","journal-title":"Biochem J"},{"issue":"8","key":"980_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrneph.2012.113","volume":"8","author":"B Hoppe","year":"2012","unstructured":"Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012;8(8):467\u201375.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"980_CR15","doi-asserted-by":"publisher","first-page":"G461","DOI":"10.1152\/ajpgi.00434.2010","volume":"300","author":"M Hatch","year":"2011","unstructured":"Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G461\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"980_CR16","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1093\/ndt\/gfr107","volume":"26","author":"B Hoppe","year":"2011","unstructured":"Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschenes G, Unwin R, Milliner D. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant. 2011;26(11):3609\u201315.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"980_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649\u201358.","journal-title":"N Engl J Med"},{"issue":"10","key":"980_CR18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/01.TP.0000084203.76110.AC","volume":"76","author":"MT Millan","year":"2003","unstructured":"Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O Jr, Esquivel CO. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation. 2003;76(10):1458\u201363.","journal-title":"Transplantation"},{"issue":"12","key":"980_CR19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/lt.24009","volume":"20","author":"P Compagnon","year":"2014","unstructured":"Compagnon P, Metzler P, Samuel D, Camus C, Niaudet P, Durrbach A, Lang P, Azoulay D, Duvoux C, Bayle F, et al. Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience. Liver Transpl. 2014;20(12):1475\u201385.","journal-title":"Liver Transpl"},{"issue":"11","key":"980_CR20","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","volume":"10","author":"EJ Bergstralh","year":"2010","unstructured":"Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS, Investigators I. Transplantation outcomes in primary hyperoxaluria. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(11):2493\u2013501.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"3","key":"980_CR21","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1111\/petr.12240","volume":"18","author":"G Naderi","year":"2014","unstructured":"Naderi G, Latif A, Tabassomi F, Esfahani ST. Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2. Pediatr Transplant. 2014;18(3):E69\u201373.","journal-title":"Pediatr Transplant"},{"issue":"2","key":"980_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ejhg.2012.139","volume":"21","author":"BB Beck","year":"2013","unstructured":"Beck BB, Baasner A, Buescher A, Habbig S, Reintjes N, Kemper MJ, Sikora P, Mache C, Pohl M, Stahl M, et al. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Eur J Hum Genet. 2013;21(2):162\u201372.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"980_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jbiosc.2012.03.014","volume":"114","author":"BT Hoa","year":"2012","unstructured":"Hoa BT, Hibi T, Nasuno R, Matsuo G, Sasano Y, Takagi H. Production of N-acetyl cis-4-hydroxy-L-proline by the yeast N-acetyltransferase Mpr1. J Biosci Bioeng. 2012;114(2):160\u20135.","journal-title":"J Biosci Bioeng"},{"issue":"29","key":"980_CR24","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1073\/pnas.1300558110","volume":"110","author":"R Nasuno","year":"2013","unstructured":"Nasuno R, Hirano Y, Itoh T, Hakoshima T, Hibi T, Takagi H. Structural and functional analysis of the yeast N-acetyltransferase Mpr1 involved in oxidative stress tolerance via proline metabolism. Proc Natl Acad Sci. 2013;110(29):11821\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"980_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/nar\/30.1.149","volume":"30","author":"S Chien","year":"2002","unstructured":"Chien S, Reiter LT, Bier E, Gribskov M. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 2002;30(1):149\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"980_CR26","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.juro.2013.03.010","volume":"190","author":"J Miller","year":"2013","unstructured":"Miller J, Chi T, Kapahi P, Kahn AJ, Kim MS, Hirata T, Romero MF, Dow JA, Stoller ML. Drosophila melanogaster as an emerging translational model of human nephrolithiasis. J Urol. 2013;190(5):1648\u201356.","journal-title":"J Urol"},{"issue":"5","key":"980_CR27","doi-asserted-by":"publisher","first-page":"e0124150","DOI":"10.1371\/journal.pone.0124150","volume":"10","author":"T Chi","year":"2015","unstructured":"Chi T, Kim MS, Lang S, Bose N, Kahn A, Flechner L, Blaschko SD, Zee T, Muteliefu G, Bond N, et al. A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease. PLoS One. 2015;10(5):e0124150.","journal-title":"PLoS One"},{"key":"980_CR28","doi-asserted-by":"crossref","first-page":"972958","DOI":"10.1155\/2014\/972958","volume":"2014","author":"S-Y Wu","year":"2014","unstructured":"Wu S-Y, Shen J-L, Man K-M, Lee Y-J, Chen H-Y, Chen Y-H, Tsai K-S, Tsai F-J, Lin W-Y, Chen W-C. An emerging translational model to screen potential medicinal plants for nephrolithiasis, an independent risk factor for chronic kidney disease. Evid Based Complement Alternat Med. 2014;2014:972958.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"980_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/mt.2016.4","volume":"24","author":"C Dutta","year":"2016","unstructured":"Dutta C, Avitahl-Curtis N, Pursell N, Larsson Cohen M, Holmes B, Diwanji R, Zhou W, Apponi L, Koser M, Ying B, et al. Inhibition of glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1. Mol Ther. 2016;24(4):770\u20138.","journal-title":"Mol Ther"},{"issue":"4","key":"980_CR30","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1074\/jbc.M112.432617","volume":"288","author":"S Fargue","year":"2013","unstructured":"Fargue S, Lewin J, Rumsby G, Danpure CJ. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele. J Biol Chem. 2013;288(4):2475\u201384.","journal-title":"J Biol Chem"},{"issue":"40","key":"980_CR31","doi-asserted-by":"publisher","first-page":"14406","DOI":"10.1073\/pnas.1408401111","volume":"111","author":"N Miyata","year":"2014","unstructured":"Miyata N, Steffen J, Johnson ME, Fargue S, Danpure CJ, Koehler CM. Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. Proc Natl Acad Sci U S A. 2014;111(40):14406\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"980_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/humu.21021","volume":"30","author":"EL Williams","year":"2009","unstructured":"Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG, Giachino D, Owen T, Robbiano A, Salido E. Mutation update. Hum Mutat. 2009;30:910\u20137.","journal-title":"Hum Mutat"},{"issue":"15","key":"980_CR33","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1007\/s00253-013-5022-7","volume":"97","author":"TM Bach","year":"2013","unstructured":"Bach TM, Takagi H. Properties, metabolisms, and applications of (L)-proline analogues. Appl Microbiol Biotechnol. 2013;97(15):6623\u201334.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"980_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1056\/NEJM198308253090801","volume":"309","author":"H Schaumburg","year":"1983","unstructured":"Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med. 1983;309(8):445\u20138.","journal-title":"N Engl J Med"},{"issue":"12","key":"980_CR35","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1136\/ard.2006.054213","volume":"65","author":"CD Silva","year":"2006","unstructured":"Silva CD, D'Cruz DP. Pyridoxine toxicity courtesy of your local health food store. Ann Rheum Dis. 2006;65(12):1666\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"46","key":"980_CR36","first-page":"2545","volume":"149","author":"MB Katan","year":"2005","unstructured":"Katan MB. How much vitamin B6 is toxic? Ned Tijdschr Geneeskd. 2005;149(46):2545\u20136.","journal-title":"Ned Tijdschr Geneeskd"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0980-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0980-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T16:33:16Z","timestamp":1751733196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0980-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0980-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were conducted according to the Guide for the Care and Use of Laboratory Animals and approved by the Animal Care and Utilization Committee of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China. Our research adhered to the Guidelines for the Care and Use of Laboratory Animals, published by the US National Institute of Health version 2011.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"167"}}